BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Receivables - Net (2021 - 2026)

Updated

Analysis

BridgeBio Pharma (BBIO) Receivables - Net (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 375.09 Mn
Jun 30, 2026 254.48 Mn
Mar 31, 2026 205.23 Mn
Dec 31, 2025 139.44 Mn
Sep 30, 2025 116.52 Mn
Jun 30, 2025 76.87 Mn
Mar 31, 2025 115.27 Mn
Dec 31, 2024 4.72 Mn
Dec 31, 2023 1.75 Mn
Jun 30, 2021 1.21 Mn
API Access

BridgeBio Pharma Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=BBIO&period=max&api_key=YOUR_API_KEY